JP2005126412A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005126412A5 JP2005126412A5 JP2004228095A JP2004228095A JP2005126412A5 JP 2005126412 A5 JP2005126412 A5 JP 2005126412A5 JP 2004228095 A JP2004228095 A JP 2004228095A JP 2004228095 A JP2004228095 A JP 2004228095A JP 2005126412 A5 JP2005126412 A5 JP 2005126412A5
- Authority
- JP
- Japan
- Prior art keywords
- propolis
- skin
- external preparation
- extracted
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000241413 Propolis Species 0.000 claims description 8
- 229940069949 propolis Drugs 0.000 claims description 8
- NGSWKAQJJWESNS-UHFFFAOYSA-N 4-coumaric acid Chemical compound OC(=O)C=CC1=CC=C(O)C=C1 NGSWKAQJJWESNS-UHFFFAOYSA-N 0.000 claims description 4
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 claims description 4
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 claims description 2
- NGSWKAQJJWESNS-ZZXKWVIFSA-M 4-Hydroxycinnamate Natural products OC1=CC=C(\C=C\C([O-])=O)C=C1 NGSWKAQJJWESNS-ZZXKWVIFSA-M 0.000 claims description 2
- DFYRUELUNQRZTB-UHFFFAOYSA-N Acetovanillone Natural products COC1=CC(C(C)=O)=CC=C1O DFYRUELUNQRZTB-UHFFFAOYSA-N 0.000 claims description 2
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 claims description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 claims description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 claims description 2
- 206010000496 acne Diseases 0.000 claims description 2
- 239000008186 active pharmaceutical agent Substances 0.000 claims description 2
- 229940093797 bioflavonoids Drugs 0.000 claims description 2
- WWVKQTNONPWVEL-UHFFFAOYSA-N caffeic acid phenethyl ester Natural products C1=C(O)C(O)=CC=C1C=CC(=O)OCC1=CC=CC=C1 WWVKQTNONPWVEL-UHFFFAOYSA-N 0.000 claims description 2
- 235000013985 cinnamic acid Nutrition 0.000 claims description 2
- 229930016911 cinnamic acid Natural products 0.000 claims description 2
- 229930004069 diterpene Natural products 0.000 claims description 2
- 150000004141 diterpene derivatives Chemical class 0.000 claims description 2
- 229940088679 drug related substance Drugs 0.000 claims description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 claims description 2
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 claims description 2
- SWUARLUWKZWEBQ-VQHVLOKHSA-N phenethyl caffeate Chemical compound C1=C(O)C(O)=CC=C1\C=C\C(=O)OCCC1=CC=CC=C1 SWUARLUWKZWEBQ-VQHVLOKHSA-N 0.000 claims description 2
- SWUARLUWKZWEBQ-UHFFFAOYSA-N phenylethyl ester of caffeic acid Natural products C1=C(O)C(O)=CC=C1C=CC(=O)OCCC1=CC=CC=C1 SWUARLUWKZWEBQ-UHFFFAOYSA-N 0.000 claims description 2
- 229960001285 quercetin Drugs 0.000 claims description 2
- 235000005875 quercetin Nutrition 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000000049 pigment Substances 0.000 description 2
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004228095A JP4212052B2 (ja) | 2003-10-01 | 2004-08-04 | 色素斑除去及び再発防止用皮膚外用剤 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003376273 | 2003-10-01 | ||
| JP2004228095A JP4212052B2 (ja) | 2003-10-01 | 2004-08-04 | 色素斑除去及び再発防止用皮膚外用剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005126412A JP2005126412A (ja) | 2005-05-19 |
| JP2005126412A5 true JP2005126412A5 (https=) | 2007-11-08 |
| JP4212052B2 JP4212052B2 (ja) | 2009-01-21 |
Family
ID=34656158
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004228095A Expired - Fee Related JP4212052B2 (ja) | 2003-10-01 | 2004-08-04 | 色素斑除去及び再発防止用皮膚外用剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4212052B2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2892923B1 (fr) * | 2005-11-08 | 2009-01-16 | Engelhard Lyon Sa | Utilisatiion des derives de l'acide para-coumarique ou para- hydroxycinnamique dans des compositions cosmetiques ou dermatologiques. |
| WO2008073684A1 (en) * | 2006-12-08 | 2008-06-19 | Lipo Chemicals Inc. | Composition for treating aging skin comprising a hydroxycinnamic acid such as p-coumaric acid |
| JP5765879B2 (ja) * | 2008-08-01 | 2015-08-19 | 小林製薬株式会社 | 蜂の子、プロポリス、およびローヤルゼリーを含有する経口摂取用組成物 |
| KR101168050B1 (ko) | 2009-08-25 | 2012-07-24 | 서울대학교산학협력단 | 카페인산 페네틸에스테르를 함유하는 비만 예방용 식품 조성물 또는 비만 치료용 제약 조성물 |
-
2004
- 2004-08-04 JP JP2004228095A patent/JP4212052B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS1500021I1 (hu) | 1,2,4-oxadiazol-benzoesav vegyületek és alkalmazásuk nonszensz szupresszióra és a betegség kezelésére | |
| CY1115940T1 (el) | Παραγωγα υποκατεστημενου φαινυλαλκανοϊκου οξεος και η χρηση τους για τη θεραπευτικη αντιμετωπιση αναπνευστικων ασθενειων | |
| WO2013185112A8 (en) | Pharmaceutical compositions for the treatment of cftr -mediated disorders | |
| ATE469163T1 (de) | Phosphonat prodrogen von einem analog des 2'- fluoro-2',3'-didehydro-2',3'-dideoxyadenosins als anti-hiv mittel | |
| EA200400881A1 (ru) | Азаарилпиперазины | |
| JP2005514441A5 (https=) | ||
| NO20076019L (no) | Utvortes preparat for hud | |
| HUP0303347A3 (en) | Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis polymorphonucleate and mononucleate cells, process for their preparation and pharmaceutical compositions containing them | |
| NO20091251L (no) | Nikotinisk acetylkolinreseptorsubtype selektive amider av diazabicykloalkaner | |
| NO20043612L (no) | Nye fluorenkarboksylsyre-estere, fremgangsmate for fremstilling derav og anvendelse derav som legemidler | |
| WO2006108582A3 (en) | Human marker genes and agents for diagnosis, treatment and prophylaxis of cardiovascular disorders and artherosclerosis | |
| WO2004032845A3 (en) | R-nsaid esters and their use | |
| DE602005007188D1 (de) | Zuckerlacton enthaltende zusammensetzung zur haarbehandlung | |
| JP2006506414A5 (https=) | ||
| JP2005126412A5 (https=) | ||
| WO2002020090A3 (en) | Pharmaceutical compositions | |
| EP2032526A4 (en) | UNSATURATED ALKYL ESTERS FROM 5-AMINOLEVULINIC ACID AND THEIR PREPARATION AND USE | |
| NO20070665L (no) | Derivater av 1-fenylalkankarboksylsyrer for behandlingen av neurodegenerative sykdommer | |
| JP2012097036A5 (https=) | ||
| NO20055367L (no) | Kombinasjoner som innbefatter paroksetin og 2-(S)-4-fluor-2-metyl-fenyl)-piperazin-1-karboksylsyer (1-(R)-(3,5-bis-trifluor-2-metyl-fenyl)-etyl]metylamid for behandling av depresjon og/eller angst | |
| CY1108425T1 (el) | Χρηση παραγωγων φαινοξυοξικου οξεος στην αντιμετωπιση της υπερλειτουργικης ουροδοχου κυστης | |
| FR2822704B1 (fr) | Sels de cetoacides et d'acides amines gastroresistants et leur utilisation pour la preparation de medicaments | |
| JP2003212765A (ja) | 水虫の活動を停止させる溶液 | |
| WO2003022218A3 (en) | Carboxylate-gated-nitroxide (cgn) compounds and compositions and methods of use thereof | |
| WO2005123651A8 (fr) | L-2-(a-hydroxypentyle)benzoates, leur elaboration et leur utilisation |